Drug
Ritlecitinib Higher Dose
Ritlecitinib Higher Dose: highest development phase Phase 3, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ritlecitinib higher dose NCT07029711 | Phase 3 | Severe Alopecia Areata |
Latest
No recent events.
Follow Ritlecitinib Higher Dose on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.